Cached score snapshot
US.EW · Edwards Lifesciences
110分制 60.4/110;5D動能v2 9/50;排序分 69.4/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +0.26% | -1.59% / +2.70% | 54.6% | 1.8% | Actual -1.98% · vs median -2.24% · inside 25-75 band |
| 30D observation | +5.17% | -1.21% / +10.93% | 71% | 14.4% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | 0.00% | -1.93% / +2.69% | 50% | 1.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-04-13 → 2026-08-19 · 380 archived points · 2 Improving turn signal · 7 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 19.7 · 資金流 14 · 5D動能v2 9
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 3.1/5 · 一般
Sub-items
資金流 — 14/20 · 良好
Sub-items
institutional
details
warning
市場環境 — 8.6/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 19.7/30 · 一般
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 6/10 · 一般
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 3.1/5分 資金流分析總分: 14/20分 市場環境分析總分: 8.6/15分 催化劑分析: 2/20分 風險管理總分: 7/10分 技術信號分析總分: 19.7/30分 情緒分析: 6/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 2.534066638188808,
"turnoverUsdM": 342.38744972,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.EW",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 88.8942,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 5.1,
"take_profit_price": 101.1225,
"target_multiplier": 2.2,
"technical_strength": 2.15,
"take_profit_percent": 8
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.5784904547178558,
"stopLossPercent": 5.068133276377616,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 69.4,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 60.4,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 9
},
"market": {
"ma20": 89.396,
"ma50": 85.9918,
"close": 93.64,
"prevClose": 94.82,
"avgVolume20": 4727806,
"volumeRatio": 0.77,
"changePercent": -1.24
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 9,
"details": {
"ret_5d": 0.03515365907583479,
"max_score": 50,
"max_total": 50,
"raw_total": 9,
"vcp_bonus": 0,
"vol_ratio": 0.7675602657181033,
"ret_points": 8,
"vol_points": 0,
"range_ratio": 0.7632214799218435,
"volat_points": 0,
"day_range_pct": 0.019596326356257944,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 69.4,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.1,
"label": "基本面",
"weight": "5/110",
"normalized": 62,
"contribution": 3.1
},
{
"raw": 14,
"label": "資金流",
"weight": "20/110",
"normalized": 70,
"contribution": 14
},
{
"raw": 8.6,
"label": "市場環境",
"weight": "15/110",
"normalized": 57.33,
"contribution": 8.6
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7,
"label": "風險管理",
"weight": "10/110",
"normalized": 70,
"contribution": 7
},
{
"raw": 19.7,
"label": "技術信號",
"weight": "30/110",
"normalized": 65.67,
"contribution": 19.7
},
{
"raw": 6,
"label": "情緒分析",
"weight": "10/110",
"normalized": 60,
"contribution": 6
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 60.4,
"details": [
"基本面分析總分: 3.1/5分",
"資金流分析總分: 14/20分",
"市場環境分析總分: 8.6/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7/10分",
"技術信號分析總分: 19.7/30分",
"情緒分析: 6/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 3.1,
"資金流": 14,
"市場環境": 8.6,
"情緒分析": 6,
"技術信號": 19.7,
"風險管理": 7
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 2,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "一般",
"items": {
"pbPoints": 0.2,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0.4,
"debtPoints": 0.5,
"marginPoints": 0.4,
"turnoverUsdM": 342.38744972,
"volumePoints": 0.5,
"revenuePoints": 0.4,
"dividendPoints": 0,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "良好",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 3.2,
"obvPoints": 4,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.EW",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 16.13
}
},
"trend": {
"score": 2.4,
"details": {
"qqq": {
"ma20": 720.20150485,
"ma50": 712.61520144,
"name": "QQQ",
"close": 711.44,
"points": 0.4
},
"spy": {
"ma20": 741.6025084,
"ma50": 739.6414025000001,
"name": "SPY",
"close": 745.40002,
"points": 2
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.534066638188808,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 2.4,
"marketTrendPoints": 2.4
}
},
"情緒分析": {
"max": 10,
"grade": "一般",
"items": {
"sentiment": {
"score": 6,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 2,
"negativeHits": 0,
"positiveHits": 1,
"sentimentScoreRaw": 1.2
}
},
"sentimentData": {
"raw": [
{
"id": 140768835,
"url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
"category": "company",
"datetime": 1782778531,
"headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
},
{
"id": 140617502,
"url": "https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.",
"category": "company",
"datetime": 1781267460,
"headline": "Should You Continue to Hold EW Stock in Your Portfolio?"
}
],
"raw_source": [
{
"id": 140841554,
"url": "https://finnhub.io/api/news?id=f808f463d5f0bb22dc96f28672fbc2e037f5d169cc4a1ef4e380aa09c200209e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "The market is focused on today's costs, but the company has already sold a future that looks entirely different.",
"category": "company",
"datetime": 1783523487,
"headline": "The One Number That Could Rewrite the Story for CoreWeave Stock"
},
{
"id": 140840980,
"url": "https://finnhub.io/api/news?id=f6b89872007a09af68ad6c31154624cb9a96d205fade79b74bd2350ac6679dce",
"image": "https://cdn.benzinga.com/files/images/story/2026/07/08/Merck-Logo--Sign-At-Merck-Research-Labor.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "EW",
"summary": "Wall St analysts changed outlook on top names. KBW cut AON PT to $400, Barclay's cut T PT to $24, MS cut ROL PT to $65, GS cut SAM PT to $169, BofA raised ALLY PT to $53, Citi raised EW PT to $110, Wells Fargo raised MRK PT to $150, Jefferies raised ENVA PT.",
"category": "company",
"datetime": 1783500020,
"headline": "Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday"
},
{
"id": 140844806,
"url": "https://finnhub.io/api/news?id=e38a7c2046c3ef3ec12c87a213c329f67f1639c81b63531e57a13e266418537b",
"image": "",
"source": "Benzinga",
"related": "EW",
"summary": "Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $101 to $110.",
"category": "company",
"datetime": 1783493221,
"headline": "Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"
},
{
"id": 140825083,
"url": "https://finnhub.io/api/news?id=d4831a06a8b6f7f3feb8ad73f380bfa82b004b8eec49a45e787a5b8408bd3d1d",
"image": "",
"source": "Benzinga",
"related": "EW",
"summary": "Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $93 to $100.",
"category": "company",
"datetime": 1783339812,
"headline": "Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100"
},
{
"id": 140785971,
"url": "https://finnhub.io/api/news?id=9417d92376a940320b0658b48d238996e548963863d2897c4d2a6cdaa04c2ccb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.",
"category": "company",
"datetime": 1782923534,
"headline": "What You Need To Know Ahead of Edwards Lifesciences' Earnings Release"
},
{
"id": 140772402,
"url": "https://finnhub.io/api/news?id=29928c6dad2caaf8f5b48d7ed19e8c0bf20103ebebf8dcb587da59e9c1cee1d6",
"image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Orlando--Fl--Usa---January-20--2022-Dard.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "EW",
"summary": "Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Canaccord cut Strategy's target, Barclays upgraded Watts Water, Rosenblatt boosted Comcast, Goldman increased State Street, Evercore raised Owens Corning, Cantor Fitzgerald boosted BioCryst Pharma, BTIG raised Edwards Lifesciences.",
"category": "company",
"datetime": 1782810296,
"headline": "Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday"
},
{
"id": 140774055,
"url": "https://finnhub.io/api/news?id=67d042810efc8c2c01c9cd0720b35451092be688f1c6d77f410c83941db8fe06",
"image": "",
"source": "Benzinga",
"related": "EW",
"summary": "BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $110.",
"category": "company",
"datetime": 1782806186,
"headline": "BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"
},
{
"id": 140768835,
"url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
"category": "company",
"datetime": 1782778531,
"headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
},
{
"id": 140765508,
"url": "https://finnhub.io/api/news?id=114499e6dd4eaa6ca7fb68293857493880ef5d632bdbecc410078617b2bb4682",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.",
"category": "company",
"datetime": 1782754560,
"headline": "Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?"
},
{
"id": 140764119,
"url": "https://finnhub.io/api/news?id=2558ab0870b5c4bd52b22a6d7cbb6ec5c9eb3d3645adb5a45d03774f7d39dc10",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards Lifesciences (EW) can sustain a high revenue growth rate given its technological leadership",
"category": "company",
"datetime": 1782750579,
"headline": "Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says"
},
{
"id": 140764120,
"url": "https://finnhub.io/api/news?id=15115c8ddf386bc50ddc3fb9d01795b6c1cbd80a889b327a585df6d4ea69da48",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.",
"category": "company",
"datetime": 1782731798,
"headline": "Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic"
},
{
"id": 140736627,
"url": "https://finnhub.io/api/news?id=617247ab6b79fad40362b749ec64c44ac950f3493e24f2fb8d960847fa1cdeb8",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "NEW YORK, June 26, 2026--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.",
"category": "company",
"datetime": 1782483300,
"headline": "Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves"
},
{
"id": 140712255,
"url": "https://finnhub.io/api/news?id=a9a0f050cff8fd433fe6026943b71c8fdff53264da5ddef0fa11d04499e6f753",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced the appointment of Ramin Mousavi as Chairman of the Board, effective immediately.",
"category": "company",
"datetime": 1782295260,
"headline": "CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board"
},
{
"id": 140692686,
"url": "https://finnhub.io/api/news?id=9136e702e7dfcc5d1df79a35985827ce407a733b50c7ff47e028abad22e65c19",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.",
"category": "company",
"datetime": 1782138480,
"headline": "Here's How Macro Trends and Currency Headwind Restrict GMED's Growth"
},
{
"id": 140691146,
"url": "https://finnhub.io/api/news?id=843562ed61fee58039a285e36f019315c1d1a32065cd26057a37a4840411af50",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "EW",
"summary": "Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
"category": "company",
"datetime": 1782131700,
"headline": "What's going on in today's pre-market session: S&P500 movers"
},
{
"id": 140649984,
"url": "https://finnhub.io/api/news?id=4d3531c17ab01cc674c5d093405b9301938682be5e2f3d2c05b0282b3d78a4fe",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.89%. June E-mini S&P futures (ESM26 ) fell -0.60%, and June E-mini Nasdaq futures...",
"category": "company",
"datetime": 1781642036,
"headline": "Stocks Indexes Finish Mostly Lower as Chipmakers Retreat"
},
{
"id": 140646075,
"url": "https://finnhub.io/api/news?id=21e901af7de0ec0c8d3fab3785c00c1c5e94d83a5ea7dcac3909c404c4549df4",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "EW",
"summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
"category": "company",
"datetime": 1781627701,
"headline": "Exploring the top movers within the S&P500 index during today's session."
},
{
"id": 140645723,
"url": "https://finnhub.io/api/news?id=079359cd4836c6e3619ed467a2a41e63411fc713f6730aadcbd94434c4558687",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards Lifesciences (EW) is expected to benefit from the Centers for Medicare & Medicaid Services'",
"category": "company",
"datetime": 1781624993,
"headline": "Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says"
},
{
"id": 140649043,
"url": "https://finnhub.io/api/news?id=ed3cde22831ae1098d949d7d33b72dd9da82db5fee1fc510faa8b2594a4fd5de",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.83%. June E-mini S&P futures (ESM26 ) are down -0.20%, and June E-mini Nasdaq futures...",
"category": "company",
"datetime": 1781622938,
"headline": "Broader Market Weakens as Energy and Software Stocks Fall"
},
{
"id": 140648875,
"url": "https://finnhub.io/api/news?id=638b4a14e4a9725ebf97bb9f2652aa7a734159b63f87d2a7f2d27b885c9ab349",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26 ) are up +0.09%, and June E-mini Nasdaq futures...",
"category": "company",
"datetime": 1781619490,
"headline": "Stocks Supported by Lower Crude Oil Prices and Bond Yields"
},
{
"id": 140657685,
"url": "https://finnhub.io/api/news?id=fa7001622e453f3c8a87f2cfb80ca9ccd62c8ad4efd0d5b139f0eda1c28b0a96",
"image": "https://cdn.benzinga.com/files/images/story/2026/06/16/Irvine--California---7-May-2023-Edwards-.jpeg?width=2048&height=1536",
"source": "Benzinga",
"related": "EW",
"summary": "CMS proposes easing TAVR coverage rules and expanding access, a move analysts say could strengthen Edwards Lifesciences' market position.",
"category": "company",
"datetime": 1781617967,
"headline": "Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device"
},
{
"id": 140654422,
"url": "https://finnhub.io/api/news?id=4310716eabd489977375bda6235de8bf999adc394f0dcb834a28574bbda42de0",
"image": "https://image.cnbcfm.com/api/v1/image/108322628-17816273621781627357-46583759523-1080pnbcnews.jpg?v=1781627361&w=1920&h=1080",
"source": "CNBC",
"related": "EW",
"summary": "The Investment Committee debate how to position your portfolio near record highs as stocks look to extend the Monday snapback.",
"category": "company",
"datetime": 1781614266,
"headline": "The market rally's road ahead: How to position near record highs"
},
{
"id": 140644822,
"url": "https://finnhub.io/api/news?id=b8ebd9a3b34af8095ea3d9e0bdd2ecb876408be3cd6107aefe82da74b3240ec6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Investing.com - U.S. stock futures were little changed on Tuesday, while oil prices extended recent losses, as investors awaited further details on a preliminary peace agreement between the United States and Iran.",
"category": "company",
"datetime": 1781613852,
"headline": "SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall"
},
{
"id": 140644730,
"url": "https://finnhub.io/api/news?id=856f656f82ba08e49ec9bf8abb135b4efc9a69ec0d62382256c4dd6e45725cdb",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "EW",
"summary": "Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.",
"category": "company",
"datetime": 1781613300,
"headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
},
{
"id": 140647034,
"url": "https://finnhub.io/api/news?id=3d96b5ea169e397d4b4305ec49ea961dfeead658b7d81538363b53ec5e3584b7",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.",
"category": "company",
"datetime": 1781607916,
"headline": "CMS proposes Medicare coverage expansion for TAVR"
},
{
"id": 140645988,
"url": "https://finnhub.io/api/news?id=c42054ddc0086ea279f32492940ebd700e57bc00d6b6d7ebb49c91219990ae2c",
"image": "",
"source": "Benzinga",
"related": "EW",
"summary": "RBC Capital analyst Shagun Singh reiterates Edwards Lifesciences (NYSE:EW) with a Outperform and maintains $100 price target.",
"category": "company",
"datetime": 1781602507,
"headline": "RBC Capital Reiterates Outperform on Edwards Lifesciences, Maintains $100 Price Target"
},
{
"id": 140617502,
"url": "https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "EW",
"summary": "Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.",
"category": "company",
"datetime": 1781267460,
"headline": "Should You Continue to Hold EW Stock in Your Portfolio?"
},
{
"id": 140582299,
"url": "https://finnhub.io/api/news?id=fb6f13d08b877506eee8ba1556c9c2305e7b73adbdfdf44d203c6b6b2cbdd90b",
"image": "https://image.cnbcfm.com/api/v1/image/108318920-17810228181781022815-46442812417-1080pnbcnews.jpg?v=1781022817&w=1920&h=1080",
"source": "CNBC",
"related": "EW",
"summary": "The Investment Committee debate the latest Calls of the Day.",
"category": "company",
"datetime": 1781008925,
"headline": "Calls of the Day: Health Care and Materials"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 2,
"negative_hits": 0,
"positive_hits": 1,
"recomputed_at_score": true,
"sentiment_score_raw": 1.2,
"source_article_count": 28,
"discarded_article_count": 26
},
"sentimentPoints": 6
}
},
"技術信號": {
"max": 30,
"raw": 19.7,
"grade": "一般",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 0.4,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 0.4,
"vcp_reason": "站上MA50;Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 7,
"vol_ref": 5182890,
"down_days": 2,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 5060610,
"avg_vol_20": 4763695,
"avg_vol_30": 5182890,
"range_pct_10": 0.11565570269115776,
"range_pct_20": 0.1401110636480137,
"range_pct_30": 0.14064502349423325,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": false,
"up_expand_days": 1,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.9764069852919897,
"dist_to_20d_high": 0.02752103022120683,
"down_shrink_days": 2,
"breakout_level_20d": 96.29,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.8223234624145794
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 0.4
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 2.534066638188808,
"turnoverUsdM": 342.38744972,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.EW",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 88.8942,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 5.1,
"take_profit_price": 101.1225,
"target_multiplier": 2.2,
"technical_strength": 2.15,
"take_profit_percent": 8
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.5784904547178558,
"stopLossPercent": 5.068133276377616,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 2.3729,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.53
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 105.27
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.0138
},
"kdj": {
"d": 81.15,
"j": 73.59,
"k": 78.63,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "入貨中",
"score": 8,
"value": 69.32
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 10,
"trend": "強流入",
"value": 49521977,
"recentSlope": 2206557.7,
"previousSlope": 12500
},
"rsi": 65.48,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 89.1449,
"position": "SAR喺價下",
"distancePct": 4.8,
"previousTrend": "上升"
},
"ma50": 85.9918,
"macd": {
"macd": 2.439536061179311,
"trend": "強烈看漲",
"signal": 1.9665366741828363,
"histogram": 0.4729993869964746
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 89.4058,
"position": "連續5日>VWAP",
"consecutiveAbove": 11
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "空升",
"ratio": 0.77,
"score": 2,
"avgVolume": 4727806,
"currentVolume": 3656423
},
"derived": {
"ma20": 89.396,
"ma50": 85.9918,
"prevClose": 94.82,
"avgVolume10": 5003432,
"avgVolume20": 4727806,
"changePercent": -1.24,
"avgVolumeForScore": 4727806
},
"ma_cross": {
"ma20": 89.396,
"ma50": 85.9918,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 89.0065,
"prevMa50": 85.802,
"spreadPct": 3.96,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 82.9818,
"upper": 95.8102,
"position": "上半部"
},
"rsi_short": 67.62,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.77
}
}
}
Raw metrics JSON
{
"close": 93.64,
"volume": 3656423,
"changePercent": -1.24
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.